Chongqing Taiji Industry(Group) Co.,Ltd

Equities

600129

CNE000000TQ2

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
36.3 CNY +3.04% Intraday chart for Chongqing Taiji Industry(Group) Co.,Ltd +7.08% -21.87%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chongqing Chinese Medicinal Materials Co., Ltd. announced that it expects to receive CNY 48 million in funding from Chongqing Taiji Industry(Group) Co.,Ltd CI
Chongqing Taiji Industry Unit's Fluoxetine Hydrochloride Capsules Passes Regulatory Evaluation MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Chongqing Taiji Industry(Group) Co.,Ltd(XSSC:600129) added to S&P Global BMI Index CI
Chongqing Taiji Industry(Group) Co.,Ltd(XSSC:600129) added to FTSE All-World Index CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chongqing Taiji Industry(Group) Co.,Ltd(SHSE:600129) added to Shanghai Stock Exchange Health Care Sector Index CI
Chongqing Taiji Industry Unit's Antibiotic Passes Regulatory Evaluation in China MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chongqing Taiji Forms Pharma Logistics JV With Affiliate MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Chongqing Taiji Industry Unit's Anti-inflammatory Medication Passes Evaluation; Shares Jump 6% MT
Chongqing Taiji to Buy TCM Maker from Controlling Shareholder for 24 Million Yuan MT
Chongqing Taiji Allots 198 Million Yuan to Build Pharmaceutical Logistics Center MT
Chongqing Taiji Industry(Group) Co.,Ltd agreed to acquire Chongqing Taiji Chinese Medicinal Materials Planting Development Co., Ltd. from Chongqing Taiji Group Co., Ltd. and Chongqing Taiji Medicinal Animal and Plant Resources Development Co., Ltd. for CNY 8.81 million. CI
Chongqing Taiji Industry(Group) Co.,Ltd agreed to acquire Chongqing Chinese Medicinal Materials Co., Ltd. from Chongqing Taiji Group Co., Ltd. for CNY 24.386 million. CI
Chongqing Taiji Gets Regulatory Nod For Levofloxacin Tablets MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Chongqing Taiji Industrygroup Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Chart Chongqing Taiji Industry(Group) Co.,Ltd
More charts
CHONGQING TAIJI INDUSTRY (GROUP) CO., LTD. is a China-based company principally engaged in the production and sales of Chinese and Western medicines. The Company is also engaged in the cultivation of medicinal herbs. The Company's products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series and injections. The Company mainly conducts its business in domestic and overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
36.3 CNY
Average target price
52.83 CNY
Spread / Average Target
+45.54%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600129 Stock
  4. News Chongqing Taiji Industry(Group) Co.,Ltd
  5. Chongqing Taiji to Buy TCM Maker from Controlling Shareholder for 24 Million Yuan